{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:12:27Z","timestamp":1772082747061,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81573043"],"award-info":[{"award-number":["81573043"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803129"],"award-info":[{"award-number":["81803129"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.intimp.2019.105968","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T01:27:26Z","timestamp":1573003646000},"page":"105968","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt\/mTOR\/p70S6K pathway in a murine model of systemic sclerosis"],"prefix":"10.1016","volume":"77","author":[{"given":"Ying","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.105968_b0005","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"issue":"Suppl 113","key":"10.1016\/j.intimp.2019.105968_b0010","first-page":"3","article-title":"One year in review 2018: systemic sclerosis","volume":"36","author":"Orlandi","year":"2018","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.intimp.2019.105968_b0015","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","article-title":"The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review","volume":"16","author":"Mostmans","year":"2017","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.intimp.2019.105968_b0020","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/1346-8138.14153","article-title":"Systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J. Dermatol."},{"key":"10.1016\/j.intimp.2019.105968_b0025","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","article-title":"Vasculopathy in scleroderma","volume":"37","author":"Asano","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.intimp.2019.105968_b0030","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","article-title":"Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis","volume":"76","author":"Manetti","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.intimp.2019.105968_b0035","doi-asserted-by":"crossref","first-page":"re8","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Gonzalez","year":"2014","journal-title":"Sci. Signal."},{"key":"10.1016\/j.intimp.2019.105968_b0040","doi-asserted-by":"crossref","first-page":"835948","DOI":"10.1155\/2013\/835948","article-title":"Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis","volume":"2013","author":"Jimenez","year":"2013","journal-title":"ISRN Rheumatol."},{"key":"10.1016\/j.intimp.2019.105968_b0045","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00441-011-1222-6","article-title":"Regulation of endothelial cell plasticity by TGF-beta","volume":"347","author":"van Meeteren","year":"2012","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.intimp.2019.105968_b0050","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.3390\/ijms18102157","article-title":"TGF-\u03b2-induced endothelial-mesenchymal transition in fibrotic diseases","volume":"18","author":"Pardali","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2019.105968_b0055","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/1755-1536-5-S1-S7","article-title":"Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases","volume":"5","author":"Piera-Velazquez","year":"2012","journal-title":"Fibrogenesis Tissue Repair."},{"key":"10.1016\/j.intimp.2019.105968_b0060","first-page":"773","article-title":"The role of the ZEB family of transcription factors in development and disease","volume":"66","author":"Vandewalle","year":"2009","journal-title":"CellMol Life Sci."},{"key":"10.1016\/j.intimp.2019.105968_b0065","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/bph.12355","article-title":"Bleomycin induces endothelial mesenchymal transition through activation of mTOR pathway: a possible mechanism contributing to the sclerotherapy of venous malformations","volume":"170","author":"Zhang","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.biopha.2017.02.098","article-title":"The activation of Akt\/mTOR pathway by bleomycin in Epithelial-to-mesenchymal transition of human submandibular gland cells: a treatment mechanism of bleomycin for mucoceles of the salivary glands","volume":"90","author":"Cai","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2019.105968_b0075","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jss.2015.02.062","article-title":"Tanshinone IIA ameliorates bleomycin-induced pulmonary fibrosis and inhibits transforming growth factor-beta-beta-dependent epithelial to mesenchymal transition","volume":"197","author":"Tang","year":"2015","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.intimp.2019.105968_b0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.vph.2018.10.004","article-title":"Protective effect of rapamycin on endothelial-to-mesenchymal transition in HUVECs through the Notch signaling pathway","volume":"113","author":"Tian","year":"2019","journal-title":"Vascul. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0085","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.3892\/mmr.2015.4645","article-title":"TGF-beta2 induces epithelial-mesenchymal transition in cultured human lens epithelial cells through activation of the PI3K\/Akt\/mTOR signaling pathway","volume":"13","author":"Guo","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2019.105968_b0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jep.2018.06.029","article-title":"Ethnopharmacology, phytochemistry, and pharmacology of Chinese Salvia species: a review","volume":"225","author":"Xu","year":"2018","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0095","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.intimp.2019.02.054","article-title":"Tanshinone IIA harmonizes the crosstalk of autophagy and polarization in macrophages via miR-375\/KLF4 pathway to attenuate atherosclerosis","volume":"70","author":"Chen","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0100","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12885-017-3329-y","article-title":"Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell","volume":"17","author":"Li","year":"2017","journal-title":"BMC Can."},{"key":"10.1016\/j.intimp.2019.105968_b0105","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.lfs.2018.11.046","article-title":"Tanshinone IIA alleviates oxidative damage after spinal cord injury in vitro and in vivo through up-regulating miR-124","volume":"216","author":"Gong","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2019.105968_b0110","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.biopha.2018.04.051","article-title":"Tanshinone IIA protects murine chondrogenic ATDC5 cells from lipopolysaccharide-induced inflammatory injury by down-regulating microRNA-203a","volume":"103","author":"Luan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2019.105968_b0115","first-page":"3299","article-title":"Inhibitory effect of tanshinone IIA on inflammatory response in rheumatoid arthritis through regulating beta-arrestin 2","volume":"17","author":"Tang","year":"2019","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2019.105968_b0120","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ejphar.2019.04.030","article-title":"Tanshinone IIA protects hypoxia-induced injury by preventing microRNA-28 up-regulation in PC-12 cells","volume":"854","author":"Tang","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0125","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.3892\/or.2014.3140","article-title":"Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1alpha downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines","volume":"31","author":"Fu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.intimp.2019.105968_b0130","doi-asserted-by":"crossref","first-page":"4247","DOI":"10.3892\/mmr.2017.6498","article-title":"Effects of tanshinone IIA on the regulation of renal proximal tubular fibrosis","volume":"15","author":"Cao","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.intimp.2019.105968_b0135","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jep.2016.12.042","article-title":"Traditional Chinese medicine for pulmonary fibrosis therapy: progress and future prospects","volume":"198","author":"Li","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.intimp.2018.04.036","article-title":"Tanshinone IIA protects against subclinical lipopolysaccharide induced cardiac fibrosis in mice through inhibition of NADPH oxidase","volume":"60","author":"Huang","year":"2018","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108676","article-title":"Preventive and therapeutic role of Tanshinone A in hepatology","volume":"112","author":"Shi","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2019.105968_b0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.intimp.2015.02.027","article-title":"Tanshinone IIA attenuates renal fibrosis and inflammation via altering expression of TGF-beta\/Smad and NF-kappaB signaling pathway in 5\/6 nephrectomized rats","volume":"26","author":"Wang","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0155","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/1472-6882-14-224","article-title":"Dissection of the mechanism of traditional Chinese medical prescription-Yiqihuoxue formula as an effective anti-fibrotic treatment for systemic sclerosis","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Complement Altern. Med."},{"key":"10.1016\/j.intimp.2019.105968_b0160","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jep.2016.12.016","article-title":"Integrative therapy decreases the risk of lupus nephritis in patients with systemic lupus erythematosus: A population-based retrospective cohort study","volume":"196","author":"Chang","year":"2017","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0165","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jep.2009.07.020","article-title":"Effects of sodium tanshinone II A sulphonate on hypoxic pulmonary hypertension in rats in vivo and on Kv2.1 expression in pulmonary artery smooth muscle cells in vitro","volume":"125","author":"Huang","year":"2009","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0170","first-page":"1025","article-title":"Geniposide inhibited endothelial-mesenchymal transition via the mTOR signaling pathway in a bleomycin-induced scleroderma mouse model","volume":"9","author":"Qi","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2019.105968_b0175","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.27498","article-title":"Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis","volume":"62","author":"Yoshizaki","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2019.105968_b0180","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.jid.2016.08.037","article-title":"Glycyrrhizin ameliorates fibrosis, vasculopathy, and inflammation in animal models of systemic sclerosis","volume":"137","author":"Yamashita","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.intimp.2019.105968_b0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/jcm5040045","article-title":"Endothelial to mesenchymal transition (EndoMT) in the pathogenesis of human fibrotic diseases","volume":"5","author":"Piera-Velazquez","year":"2016","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.intimp.2019.105968_b0190","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.canlet.2012.08.016","article-title":"The PI3K\/Akt\/mTOR signaling pathway mediates insulin-like growth factor 1-induced E-cadherin down-regulation and cell proliferation in ovarian cancer cells","volume":"326","author":"Lau","year":"2012","journal-title":"Can. Lett."},{"key":"10.1016\/j.intimp.2019.105968_b0195","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/art.37988","article-title":"Review: evidence that systemic sclerosis is a vascular disease","volume":"65","author":"Matucci-Cerinic","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2019.105968_b0200","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2019.105968_b0205","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jss.2016.04.066","article-title":"Tanshinone IIA attenuates epithelial-mesenchymal transition to inhibit the tracheal narrowing","volume":"206","author":"Duan","year":"2016","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.intimp.2019.105968_b0210","first-page":"137","article-title":"Clinical efficiency of tanshinone IIA-sulfonate in treatment of liver fibrosis of advanced schistosomiasis","volume":"25","author":"Niu","year":"2013","journal-title":"Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi."},{"key":"10.1016\/j.intimp.2019.105968_b0215","doi-asserted-by":"crossref","first-page":"250","DOI":"10.6061\/clinics\/2015(04)06","article-title":"Tanshinone IIA attenuates interleukin-17A-induced systemic sclerosis patient-derived dermal vascular smooth muscle cell activation via inhibition of the extracellular signal-regulated kinase signaling pathway","volume":"70","author":"Liu","year":"2015","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.intimp.2019.105968_b0220","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1038\/s41598-019-42164-3","article-title":"Proteomic analysis reveals novel insights into tanshinones biosynthesis in Salvia miltiorrhiza hairy roots","volume":"9","author":"Contreras","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.intimp.2019.105968_b0225","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/aps.2017.193","article-title":"Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.intimp.2019.105968_b0230","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.biopha.2018.12.016","article-title":"Salvianolic acid B attenuates experimental skin fibrosis of systemic sclerosis","volume":"110","author":"Liu","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2019.105968_b0235","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejphar.2019.03.021","article-title":"Tanshinone I inhibits vascular smooth muscle cell proliferation by targeting insulin-like growth factor-1 receptor\/phosphatidylinositol-3-kinase signaling pathway","volume":"853","author":"Wu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2019.105968_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12659\/AOT.906700","article-title":"Antifibrotic effects of hepatocyte growth factor on endothelial-to-mesenchymal transition via transforming growth factor-beta1 (TGF-beta1)\/Smad and Akt\/mTOR\/P70S6K signaling pathways","volume":"23","author":"Wang","year":"2018","journal-title":"Ann. Transplant."},{"key":"10.1016\/j.intimp.2019.105968_b0245","first-page":"1221","article-title":"Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease","volume":"139","author":"Milani","year":"1991","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.intimp.2019.105968_b0250","first-page":"4065","article-title":"Endothelial cells from different anatomical origin have distinct responses during SNAIL\/TGF-beta2-mediated endothelial-mesenchymal transition","volume":"10","author":"Pinto","year":"2018","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.intimp.2019.105968_b0255","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1002\/jcp.22648","article-title":"TGFbeta- and bleomycin-induced extracellular matrix synthesis is mediated through Akt and mammalian target of rapamycin (mTOR)","volume":"226","author":"Goc","year":"2011","journal-title":"J. Cell Physiol."}],"updated-by":[{"DOI":"10.1016\/j.intimp.2020.106318","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000}}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919311257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919311257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T17:16:14Z","timestamp":1761585374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919311257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":51,"alternative-id":["S1567576919311257"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105968","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tanshinone IIA ameliorates the bleomycin-induced endothelial-to-mesenchymal transition via the Akt\/mTOR\/p70S6K pathway in a murine model of systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.105968","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105968"}}